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and ammonia concentrations [8], the presence of hepatic
encephalopathy [9], the presence of ascites and the pro- and
anti-inﬂammatory cytokine milieu [10] which warrant further
investigation. The quest for the elusive factor(s) that underpin
neutrophil function therefore continues.
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k Vijay and colleagues for their appreciation and interest
aper evaluating some features of neutrophil dysfunction
sis of different severity [1].
raise three points which are addressed below:
rst issue raised was over concerns for the high variability
agocytic capacity in the group of healthy controls and the
rous factors inﬂuencing neutrophil function, which may
r the statistical evaluation of differences. We used
a from 21 healthy controls who were non-smokers and
not drunk alcohol in the previous 48 h. For cytokine
s we used 10 healthy controls. With regards to variabil-
e would suggest that it was even higher in the cirrhosis
, with some patients showing higher phagocytic capacity
controls. In general, variability is a normal component of
ologic phenomena and an ever-present bystander in all
rimental models. Statistical methods are speciﬁcally
d at evaluating whether the differences between two
s are secondary to casual variability or not. In this spe-
experiment, despite some overlap of phagocytic capacity
een patients and control, the probability of the null-hyp-
s was calculated as less than 1 in 10,000, a quite reassur-
alue. On the other hand, one may argue that also some
tive results (i.e. accepting the null hypothesis or non-sta-
tistically signiﬁcant differences) can actually be the conse-
quence of high variability. In fact, in our discussion we
focused only on the results supported by strong statistical sig-
niﬁcance. In addition, the observations of Vijay and colleagues
give us the opportunity to stress once again that all patients
with liver cirrhosis are not the same and better understanding
of the reason for such wide variations is needed. It is therefore
remarkable the constant and invariable near to complete loss
of phagocytic capacity of neutrophils migrating to the skin
blisters of cirrhotic patients, indicating that patients with cir-
rhosis have evidence of marked neutrophil dysfunction.
2. The ‘‘control’’ TLR expression in Fig. 4 refers to neutrophils
incubated with healthy control’s plasma as stated in the ‘‘Sub-
jects’’ paragraph and similar to all other experiments as stated
in the Materials and methods section.
3. We found a trend towards higher oxidative burst in patients
with alcoholic aetiology, ascites or encephalopathy (not statis-
tically signiﬁcant). We preferred to focus and comment only
on results supported by strong statistical signiﬁcance.
The preliminary data Vijay et al. refer to are interesting and
we understand consistent with our results. Further understand-
ing of the underlying mechanisms will allow development of
new strategies that can reduce the risk of infection in liver
disease.
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20,70-Dichloroﬂuorescein is not a probe for the detection
of reactive oxygen and nitrogen species
To the Editor:
In a recent issue of this Journal, Llacuna and colleagues [1]
reported on the pivotal role of mitochondrial cholesterol accumu-
lation and aggravated oxidative stress in the pathophysiology of
ischemia–reperfusion (IR) injury in the fatty liver. Steatotic mur-
ine livers were subjected to 60 min of warm ischemia followed by
a non-speciﬁed period of reperfusion. During reperfusion, part of
the liver was incubated for 45 min with 200 lM 20,70-dichloroﬂu-
orescein (DCF) by means of superfusion and subsequently imaged
by in vivo confocal microscopy, whereby DCF ﬂuorescence was
considered a direct measure of reactive oxygen species (ROS)
generation. The data obtained with this technique served as the
main premises for the conclusions related to intrahepatic oxida-
tive stress.
However, DCF is not commonly used for the detection of ROS.
Rather, the non-ﬂuorescent 20,70-dichlorodihydroﬂuorescein
diacetate (DCFH2-DA) is employed. DCFH2-DA enters cells by pas-
sive diffusion. Inside the cytosol, esterases remove the acetate
groups to form the non-ﬂuorescent derivative 20,70-dichlorodihy-
droﬂuorescein (DCFH2). Upon exposure to ROS as well as other
oxidants such as reactive nitrogen species (RNS), DCFH2 under-
goes two-electron oxidation, resulting in generation of the highly
ﬂuorescent DCF (Fig. 1A). Accordingly, the extent of DCF ﬂuores-
cence can be employed as a measure of the degree of oxidative/
nitrosative stress, i.e., a state in which the generation of ROS/
RNS outweighs the cell’s antioxidative capacity [2].
Several experiments were performed to demonstrate the erro-
neous use of the probe. Firstly, the uptake of DCF by cultured
human hepatocellular carcinoma (HepG2) cells was assessed. It
was shown that DCF indeed accumulates in HepG2 cells at con-
centrations >20 lM (Fig. 1B and C).
Next, transcapsular penetration and hepatocellular uptake of
DCF were evaluated in vivo. Superfusion of murine livers with
DCF for 45 min resulted in marginal tissue penetration at best,
with DCF ﬂuorescence only exceeding background ﬂuorescence
intensity at the capsular interface (Fig. 1D, arrow).
To investigate whether DCF ﬂuorescence increases upon oxida-
tion, as reported by Llacuna et al. [1], DCFwas incubatedwith Fenton
reaction-derived hydroxyl radicals (OH) [3]. A decrease in DCF ﬂuo-
rescence emission was observed following the addition of hydrogen
peroxide (H2O2) to theDCF/iron(II)mixture,which led to the produc-
tion of OH (Fig. 1E) [3]. This is consistent with an earlier report that
identiﬁedDCF as a target for oxidation [4], but unequivocally revokes
the conclusions of Llacuna and colleagues [1], who posited that DCF
ﬂuorescence intensiﬁes as ROS production increases.
Conclusively, the proposition that DCF functions as an indicator
for ROS production could not be conﬁrmed. Rather, the opposite
effects were observed, as evinced by the steep drop in DCF ﬂuores-
cence upon OH generation. The data hence refute the oxidative
stress-related conclusions by Llacuna et al. [1]. DCF is the end-
product of a free radical species-speciﬁc ﬂuorogenic probe (i.e.,
DCFH2-DA/DCFH2) rather than a probe for the direct visualization
of ROS/RNS. Moreover, DCF appears to be oxidized to a non-ﬂuo-
rescent, yet unidentiﬁed, compound in the presence of OH, reduc-
ing the ﬂuorescence intensity at 523 nm and thus reﬂecting an
underestimated extent of intracellular ROS/RNS production.
Apart from the apparent misuse and subsequent misinterpreta-
tion of the results, two additional issues should be addressed. First,
despite the fact that DCFH2-DA and DCFH2 are amongst the most
common probes for the detection of ROS/RNS, little is known about
the cellular behavior of these compounds. Although strongly stressed
bysome[5], studies that speciﬁcally investigateDCFH2-DAandderiv-
atives with respect to cellular kinetics, localization, and toxicity
remain scarce to date [6,7]. The elusive intracellular kinetics and
dynamics of DCFH2-DA and derivatives could lead to wrongful use
of the probe and hence misinterpretation of experimental results.
The second issue that exacts attention is the need to accu-
rately describe and perform experimental procedures so as to
ensure reproducibility and prevent the use of faulty methodolo-
gies, respectively. The incorrect use of materials or, for that mat-
ter, incorrect reporting on use of the proper materials (e.g.,
reporting on the use of DCF when actually DCFH2-DA was
employed instead), which can be found in various articles pub-
lished in 2010/11 alone [8–10], could lead to widespread misap-
plication of the probe and the erroneous formulation of
conclusions. This is especially important in regard to the data
of Llacuna et al. [1], where it appears that a conclusion was drawn
on the basis of incorrectly performed experiments.
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